
    
      The study will consist of 2 treatment arms:

      Treatment arm A: Intra-operative single intravenous(iv) dose of "cephalexin" 2 g or
      "clindamycin" 900 mg.

      Treatment arm B: Intra-operative single intravenous(iv) dose of "cephalexin" 2 g or
      "clindamycin" 900 mg and postoperative oral dose of "cephalexin" 250mg every 4 hours or
      "clindamycin" 150mg every 6 hours, for a duration of three days.
    
  